These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6684202)

  • 1. Chronic administration of three neuroleptics: effects of behavioral supersensitivity mediated by two different brain regions in the rat.
    Halperin R; Guerin JJ; Davis KL
    Life Sci; 1983 Aug; 33(6):585-92. PubMed ID: 6684202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional differences in the induction of behavioral supersensitivity by prolonged treatment with atypical neuroleptics.
    Halperin R; Guerin JJ; Davis KL
    Psychopharmacology (Berl); 1989; 98(3):386-91. PubMed ID: 2568659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.
    Seeger TF; Thal L; Gardner EL
    Psychopharmacology (Berl); 1982; 76(2):182-7. PubMed ID: 6805029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of thioridazine on haloperidol induced behavioral hypersensitivity.
    Klawans HL; Carvey PM; Nelson D; Tanner CM; Goetz CG
    Life Sci; 1986 May; 38(19):1707-14. PubMed ID: 3702600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locomotor stereotypy is produced by methylphenidate and amfonelic acid and reduced by haloperidol but not clozapine or thioridazine.
    Mueller K
    Pharmacol Biochem Behav; 1993 May; 45(1):71-6. PubMed ID: 8100075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine.
    Smith RC; Davis JM
    Life Sci; 1976 Sep; 19(5):725-31. PubMed ID: 986527
    [No Abstract]   [Full Text] [Related]  

  • 7. Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy.
    Tschanz JT; Rebec GV
    Pharmacol Biochem Behav; 1988 Nov; 31(3):519-22. PubMed ID: 3251235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic thioridazine treatment differently affects DA receptors in striatum and in mesolimbo-cortical systems.
    Piazza PV; Calzà L; Giardino L; Amato G
    Pharmacol Biochem Behav; 1990 Apr; 35(4):937-42. PubMed ID: 2345767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute thioridazine stimulates mesolimbic but not nigrostriatal dopamine release: demonstration by in vivo electrochemistry.
    Lane RF; Blaha CD
    Brain Res; 1987 Apr; 408(1-2):317-20. PubMed ID: 2439169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigm.
    Carvey PM; Nath ST; Kao LC; Zhang TJ; Lin DH; Singh R; Amdur RL; Klawans HL
    Eur J Pharmacol; 1990 Aug; 184(1):43-53. PubMed ID: 2209714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluotracen: a tricyclic compound with the combined properties of antidepressants and antipsychotics in animals.
    Fowler PJ; Zirkle CL; Macko E; Setler PE; Sarau HM; Misher A; Tedeschi DH
    Arzneimittelforschung; 1977; 27(8):1589-95. PubMed ID: 410422
    [No Abstract]   [Full Text] [Related]  

  • 13. Behavioral effects of a dimethylsulfonium analog of dopamine after injection into the nucleus accumbens and the striatum.
    Boldry R; Chang Y; Miller DD; Uretsky NJ
    Pharmacol Biochem Behav; 1986 Feb; 24(2):223-8. PubMed ID: 3081914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of microinjection of 2-chloro-11 (2-dimethylaminoethoxy)-dibenzo[b,f]-thiepine (zotepine), thioridazine and haloperidol into the striatum and nucleus accumbens on stereotypic behaviour and motor activity.
    Lai H; Carino MA; Sperry R; Horita A
    J Pharm Pharmacol; 1981 Apr; 33(4):252-4. PubMed ID: 6115914
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity.
    Carvey PM; Kao LC; Zhang TJ; Amdur RL; Lin DH; Singh R; Klawans HL
    Pharmacol Biochem Behav; 1990 Feb; 35(2):291-300. PubMed ID: 2320636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioridazine chronic administration: a behavioural and autoradiographic study.
    Calzà L; Giardino L; Piazza PV; Amato G
    Neurosci Lett; 1990 Feb; 109(1-2):206-11. PubMed ID: 2314636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diazepam potentiates the effect of neuroleptics on behavioural activity as well as dopamine and norepinephrine turnover: Do benzodiazepines have antipsychotic potency?
    Singhal RL; Rastogi RB; Lapierre YD
    J Neural Transm; 1983; 56(2-3):127-38. PubMed ID: 6306165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
    Lynch MR
    Neuropsychobiology; 1990-1991; 24(2):102-8. PubMed ID: 2151972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
    Compton DR; Johnson KM
    J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The action of neuroleptics in rats with altered catecholamine metabolism. I. The influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol, and thioridazine.
    Vetulani J
    Pol J Pharmacol Pharm; 1973; 25(1):41-52. PubMed ID: 4798098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.